| Clinical data | |
|---|---|
| Other names | Anapregnone; 3-Deketo-6α-methyl-17α-hydroxyprogesterone; 6α-Methyl-17α-hydroxypregn-4-en-20-one |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C22H34O2 |
| Molar mass | 330.512 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Anagestone (INNTooltip International Nonproprietary Name), also known as3-deketo-6α-methyl-17α-hydroxyprogesterone or as6α-methyl-17α-hydroxypregn-4-en-20-one, is aprogestin which was never marketed.[1]
Anacylated derivative,anagestone acetate, was formerly used clinically as apharmaceuticaldrug.[1]
Whileanagestone is sometimes used as a synonym foranagestone acetate, it usually refers to anagestone acetate, not anagestone.
Thisdrug article relating to thegenito-urinary system is astub. You can help Wikipedia byexpanding it. |